ZNF407 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.26350000462239E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.89200002518464E-09 |
Normal-vs-Stage2 |
8.30440000000321E-05 |
Normal-vs-Stage3 |
8.12060000000558E-05 |
Normal-vs-Stage4 |
1.27670000016344E-07 |
Stage1-vs-Stage2 |
6.982000E-01 |
Stage1-vs-Stage3 |
9.316000E-01 |
Stage1-vs-Stage4 |
1.021830E-01 |
Stage2-vs-Stage3 |
6.823800E-01 |
Stage2-vs-Stage4 |
3.631600E-02 |
Stage3-vs-Stage4 |
1.423770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.28830000001301E-08 |
Normal-vs-AfricanAmerican |
1.67559999997291E-06 |
Normal-vs-Asian |
4.83259999994878E-06 |
Caucasian-vs-AfricanAmerican |
9.832600E-01 |
Caucasian-vs-Asian |
1.792360E-01 |
AfricanAmerican-vs-Asian |
1.406630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.9450000478023E-10 |
Normal-vs-Female |
1.963320E-03 |
Male-vs-Female |
2.019100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.31719999999447E-05 |
Normal-vs-Extreme_Weight |
9.07509956071806E-10 |
Normal-vs-Obese |
2.37220000000038E-05 |
Normal-vs-Extreme_Obese |
3.407100E-04 |
Normal_Weight-vs-Extreme_Weight |
2.596600E-01 |
Normal_Weight-vs-Obese |
7.423600E-01 |
Normal_Weight-vs-Extreme_Obese |
8.696800E-01 |
Extreme_Weight-vs-Obese |
7.713700E-02 |
Extreme_Weight-vs-Extreme_Obese |
6.145800E-01 |
Obese-vs-Extreme_Obese |
6.697400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.398500E-03 |
Normal-vs-Age(41-60Yrs) |
2.12450000003361E-06 |
Normal-vs-Age(61-80Yrs) |
7.83059950215659E-10 |
Normal-vs-Age(81-100Yrs) |
2.10869999994756E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.962600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.822790E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.113370E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.246100E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.837050E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.657200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.65260000128953E-08 |
Normal-VS-Type2 PRCC |
4.12809999517094E-08 |
Normal-VS-KIRP CIMP |
4.993900E-04 |
Normal-VS-Unclassified PRCC |
5.256700E-03 |
Type1 PRCC-VS-Type2 PRCC |
2.511600E-01 |
Type1 PRCC-VS-KIRP CIMP |
9.166600E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.878570E-01 |
Type2 PRCC-VS-KIRP CIMP |
6.835800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
5.514400E-02 |
KIRP CIMP-VS-Unclassified PRCC |
4.661000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.96230000529363E-08 |
Normal-vs-N1 |
2.78170000000966E-06 |
Normal-vs-N2 |
3.020700E-03 |
N0-vs-N1 |
9.573800E-01 |
N0-vs-N2 |
8.077800E-01 |
N1-vs-N2 |
8.005000E-01 |
|
|